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Abstract
There is consensus on the benefits for all infants of exclusive breastfeeding for 6 months and
introduction of appropriate complementary foods at 6 months, followed by continued
breastfeeding. However, guidelines on infant and young child feeding (IYCF) for HIV-positive
mothers have changed continually since 2000. This article explores issues and evidence related to
IYCF for the prevention and care of paediatric HIV in resource-limited settings in light of new
HIV treatment guidelines, implementation challenges and knowledge gaps.
In 2010 the impact of antiretroviral drugs (ARVs) on reducing the risk of mother-to-child
transmission of HIV moved WHO to urge countries to endorse either avoidance of all
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breastfeeding or exclusive breastfeeding for the first 6 months while taking ARVs, depending on
which strategy could give their infants the greatest chance of HIV-free survival. Implementation
of the 2010 recommendations is challenged by lack of healthcare provider training, weak clinic–
community linkages to support mother/infant pairs and lack of national monitoring and reporting
on infant feeding indicators.
More evidence is needed to inform prevention and treatment of malnutrition among HIV-exposed
and HIV-infected children. Knowledge gaps include the effects of prolonged ARV exposure, the
cause of HIV-associated growth faltering, the effects of early infant testing on continuation of
breastfeeding and specific nutrition interventions needed for HIV-infected children.
Significant progress has been made toward keeping mothers alive and reducing paediatric HIV
infection, but sustained political, financial and scientific commitment are required to ensure
meaningful interventions to eliminate postnatal transmission and meet the nutritional needs of
HIV-exposed and HIV-infected children.
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Introduction
Evidence-based guidelines in place since 2010 recommend that mothers with HIV in low-
resource/high-HIV burden settings receive the same infant and young child feeding (IYCF)
advice as HIV-uninfected mothers: early initiation of breastfeeding within 1 hour of birth,
exclusive breastfeeding (EBF) for the first 6 months and introduction of appropriate
complementary foods at 6 months, followed by continued breastfeeding [1]. Despite this
uniformity of guidelines for all infants, factors including rapidly changing global
recommendations, slow rollout of updated national guidelines resulting in late training of
healthcare providers, unsafe traditions and taboos related to breastfeeding, lack of support
for breastfeeding mothers and significant evidence gaps in programmatic experience have
led to on-going confusion about and poor adherence to these strategies [2–4]. Changes in
guidelines and underlying poor complementary feeding practices among the general
population have made it particularly challenging to implement safe weaning and adequate
complementary feeding practices.
As remaining questions are answered and recommendations evolve, mothers with HIV need
up-to-date, clear messages on and support for optimal IYCF practices. This article is not a
systematic review but rather explores issues and evidence related to IYCF practices in
resource-limited settings in light of the WHO 2010 HIV and infant feeding guidelines and
2013 Consolidated guidelines, implementation challenges and knowledge gaps that limit
optimal care of HIV-exposed and HIV-infected infants and young children, and calls for
program implementers to pay attention to critical nutrition issues that are emerging for these
children.
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Evidence and guidelines on HIV and child nutrition
Evidence suggests that children born to women with HIV are at higher risk of morbidity [5]
and mortality [6,7] than their non-exposed peers. There is substantial evidence that women
with HIV are more likely to have infants who are small for gestational age [8,9] and that
HIV-exposed infants are more likely to be preterm or low birth weight [10].
Although in-utero HIV infection has not been proven to affect foetal growth, HIV affects
postnatal growth starting in the early months of life, often before other signs of infection
appear, and is strongly associated with both wasting and poor linear growth. Severe wasting
is the most visible sign of possible HIV infection, but linear growth faltering is also common
in HIV-infected children and may be a better indicator of disease progression than severe
wasting [11]. Poor growth can be caused by HIV itself; opportunistic infections or
medication side-effects that alter food intake, absorption and metabolism; diarrhoea and
other childhood illnesses; poverty and food insecurity.
Unexplained under-nutrition that does not respond to standard treatment may be a sign of
advanced HIV disease, and HIV testing should be part of the standard management of
malnourished children. Malnourished HIV-infected children lose more muscle and have a
higher risk of mortality than their uninfected malnourished peers [12] and, like adults,
experience metabolic changes that may increase morbidity.
First 6 months of life
Well documented benefits of breastfeeding include improved infant immunity and thus
decreased morbidity and mortality from disease, improved paediatric development, and
health benefits for mothers including natural birth spacing, improved maternal-child bonding
and economic and environmental benefits [13].
Infants who are fed foods or liquids in addition to breast milk (mixed feeding) or instead of
breast milk (replacement feeding) during the first 6 months of life are at increased risk of
morbidity and mortality from unsafe water, inadequate formula preparation or storage,
unsanitary conditions and formula shortages, particularly in low-resource settings.
Programmes have reported that in order to avoid social pressure associated with not
breastfeeding, women with HIV often breastfeed in public while also privately feeding
formula or other foods and liquids to infants younger than 6 months. This mixed feeding, in
addition to the risks mentioned above, increases the risk of vertical transmission [14]. For
these reasons, women have long been encouraged to breastfeed exclusively for the first 6
months.
IYCF guidance for HIV-exposed children has continued to evolve since WHO issued its first
infant feeding technical consultation consensus statement in 2000 [15]. The risk of HIV
transmission from breastfeeding up to 18–24 months is 15–20%, but studies in low-resource
environments have concluded that not breastfeeding or stopping breastfeeding early
increased mortality and reduced HIV-free survival [16,17]. Additional studies have found
that safer practices such as exclusive breastfeeding for the first 6 months, proper breast
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health management, and antiretroviral therapy (ART) for the mother and infant during the
breastfeeding period, significantly lowers the risk of HIV transmission [18,19].
In 2006, WHO recommended that mothers with HIV choose between 1) exclusive
breastfeeding for 6 months or 2) exclusive replacement feeding for 6 months if acceptable,
feasible, affordable, sustainable and safe (AFASS) [20]. Mothers who chose EBF were
advised to continue breastfeeding until they could provide a safe and adequate replacement
diet. By 2010 data on the impact of antiretroviral drugs (ARVs) on reducing the risk of
mother-to-child transmission of HIV and increased all-cause mortality among infants who
were not exclusively breastfed moved WHO to update its recommendations again: this time
urging countries to endorse one nationwide infant feeding recommendation for women with
HIV – either avoid all breastfeeding, or breastfeed while taking ARVs. In countries that
adopted breastfeeding as the policy, women with HIV are encouraged to continue
breastfeeding for at least 1 year and until a nutritionally adequate and safe diet without
breast milk can be provided. Even where ARVs are not available, WHO recommends
breastfeeding of HIV-exposed infants [1].
The rapid change in global recommendations for infant feeding in the context of HIV only
partly explains confusion about what to advise mothers with HIV. Countries are often slow
to adopt new global guidelines, and face challenges in retraining healthcare providers and
addressing norms among mothers. However, the latest WHO guidelines provide an
opportunity for HIV and child survival communities to harmonize and promote common
feeding messages for all children, including those who are HIV-exposed, during the first
year of life.
Second 6 months of life
For the first 12 months of life, the high levels of nutrients in breast milk protects against
mortality from diarrhoea, pneumonia and malnutrition. However, around the age of 6
months, breast milk alone can no longer meet all nutritional requirements of the infant, and
complementary feeding – the transition from exclusive breastfeeding to family foods – is
necessary. Although complementary foods provide energy and nutrients to help meet the
growing child’s needs, breastfeeding continues to provide at least half of a child’s nutritional
requirements between the ages of 6 to 12 months (Fig. 1). Changes in advice on how long
women with HIV should breastfeed beyond 6 months and changes in ARV prophylaxis and
treatment regimens have been a source of significant confusion for healthcare providers. As
recently as 10 years ago, mothers with HIV were advised to stop breastfeeding at 4–6
months [21]. However, evidence of growth failure, increased morbidity from diarrhoea and
all-cause mortality among these infants demonstrated that it was not advisable for mothers
with HIV to stop breastfeeding at that time [20,22]. The lack of safe alternative milks, the
continued burden of infectious diseases and the risk of growth faltering in children 6–12
months of age underscore the on-going value of breastfeeding. Breast-milk contains growth
factors such as epidermal growth factor and transforming growth factor β, which may
enhance the maturation of the gut epithelial barrier by strengthening its integrity and
hindering passage of the virus [23]. Because the risk of HIV transmission decreases as a
child’s gut matures, mixed feeding does not carry the same risk after the age of 6 months.
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ARVs that reduce the risk of HIV transmission through breastfeeding have shifted the risk/
benefit analysis in favour of breastfeeding. Several important trials with differing ARV
approaches have demonstrated that mothers with HIV can breastfeed safely for longer
durations and that this can be lifesaving for their infants. Although longer-term exposure to
ARVs may have undiscovered consequences, the best available evidence suggests that the
risks of infants dying from other diseases if breastfeeding stops before the age of 1 are
greater than the potential side-effects of prolonged drug exposure.
Adherence to complementary feeding guidelines is generally poor in most low-resource
contexts [24]. Complementary foods are often introduced too early or too late, with little
variety and inadequate portions, and food safety is often poor. As a result, growth faltering
often increases dramatically during the complementary feeding period, along with the risk of
stunting. Providing complementary foods to HIV-exposed and HIV-infected children is even
more challenging as they may lack appetite or suffer from other factors that reduce food
intake or increase nutrient losses [8].
Second year of life
Although experts agree that mothers with HIV should breastfeed for at least 1 year, the
optimal duration of breastfeeding beyond 12 months is uncertain. Some question the need
for any limitation. For the first 12 months of life, the high levels of nutrients and
immunologic benefits of breast milk protects against mortality from diarrhoea, pneumonia
and malnutrition [Table 1]. While breast milk continues to provide significant health
benefits after 12 months, there is a less compelling benefit in terms of reduced mortality
because older children are better able to recover from childhood illnesses. Moreover, after
12 months of age, a child’s nutritional needs can be met more easily by family foods that
include an age-appropriate amount of cow’s milk.
Mothers with HIV should be advised to stop breastfeeding only when they can provide ‘a
nutritionally adequate and safe diet’ without breast milk after 12 months. Otherwise, they
should continue breastfeeding beyond 12 months while remaining on (and adhering to)
ARVs. Whenever they decide to stop breastfeeding, weaning should be done gradually,
within 1 month, although the optimal approach and length of the cessation process is not
known. Weaning abruptly is not advisable, as some studies found it to be is associated with
mastitis and elevated viral load in breast milk [25–27]. HIV-infected children can continue
breastfeeding for up to 2 years or longer, as breastfeeding increases their chance of survival
[1].
Antiretroviral therapy and breastfeeding
To prevent postnatal vertical transmission of HIV, mothers should take ARVs as
prophylaxis or as therapy for their own health throughout the duration of breastfeeding to
reduce viral load, and their infants should receive ARVs for 4–6 weeks after birth. The 2010
WHO Guidelines on HIV and Infant Feeding reflect evidence of the benefits of both
breastfeeding and the ability of ARVs for either mothers or infants during breastfeeding to
reduce the risk of postnatal HIV transmission significantly. With these recommendations,
ARV prophylaxis during breastfeeding became part of the public health approach to
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prevention of mother-to-child transmission of HIV (PMTCT). With changes in CD4
eligibility and the introduction of life-long ART for pregnant women regardless of CD4 cell
count (Option B+), more pregnant and lactating women with HIV are eligible for ART.
These advances can not only prevent postnatal HIV transmission through breastfeeding, but
can also reduce transmission risk in future pregnancies while sustaining the health of
mothers.
The 2013 WHO Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating
and Preventing HIV Infection maintain that the primary aim of the HIV and infant feeding
recommendations is to improve HIV-free survival by reducing the risk of transmission
through breastmilk using ARVs, while avoiding malnutrition and the increased risk of
serious infections in infants and children from unsafe feeding practices [28]. The efficacy of
ARVs to prevent postnatal transmission depends largely on whether women with HIV take
ARVs consistently throughout breastfeeding. If treatment is interrupted for any reason,
virologic failure and drug resistance may result and lead to increased transmission,
morbidity and mortality [29]. Supporting mothers with HIV to remain on ART is essential,
given numerous individual and health system challenges. The 2013 guidelines include a
chapter on retention across the continuum of care and build the case for investing in
improved health systems to provide a quality of care commensurate with the needs of
mothers and children. For mothers without access to ARVs, optimal infant feeding remains
critical to minimize the risk of vertical transmission.
Antiretroviral therapy and child nutrition
Many recent studies show that ART can lead to significant improvement in both weight and
height of HIV-infected children. Its effect on growth appears to be most pronounced in
younger children before chronic under-nutrition (stunting) has become permanent, and in
children with less severe growth deficiencies at initiation of treatment [30–32]. However,
ART alone does not appear to help children achieve full growth recovery or sustain their
growth over the long-term [33]. Moreover, a recent study found that children who were
underweight when they began ART had worse immunological outcomes [34], highlighting
the importance of aggressive case-finding of unrecognized HIV among malnourished
children and non-medical strategies such as IYCF counselling and improved water,
sanitation and hygiene to avoid growth faltering and improve treatment outcomes.
Food supplementation and fortification for HIV-infected children
HIV-infected children have higher energy needs than HIV-negative children. It is
recommended that HIV-infected children consume 10% more energy than HIV-negative
children if asymptomatic, 20–30% more energy if they have opportunistic infections and
50–100% more energy during and after episodes of severe acute malnutrition to recover lost
weight [35]. Eating more energy-rich food can help HIV-infected children to gain weight.
However, poor linear growth has an even stronger association with HIV viral load. The
relationship between viral load and growth is not well understood but could involve several
disease-related endocrine and metabolic changes. HIV-infected children are also especially
vulnerable to the diarrhoeal disease and gastrointestinal infections that are common causes
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of malnutrition in the general population. Diarrhoea-related nutrient losses, malabsorption
and inadequate feeding practices for catch-up growth may all contribute to malnutrition in
these children.
A 2010 Cochrane review concluded that vitamin A supplementation is well tolerated and is
beneficial for HIV-infected children and that zinc is as well tolerated and is possibly as
beneficial for HIV-infected children as for uninfected children. Further trials of other
supplements (vitamin D, zinc and selenium) are needed to advance the evidence base and
evaluate long-term benefits, adverse effects and optimal formulations of multiple
micronutrient supplements [36].
Operational and programmatic challenges to consider
Given the historical confusion about HIV and infant feeding messages, high rates of
malnutrition and poor IYCF practices in many settings, programme managers need to
consider operational and programmatic challenges at each stage of service delivery to ensure
effective, uninterrupted patient-centred care.
At community level
To strengthen the adoption of IYCF counselling recommendations by mothers with HIV and
ensure nutrition care and follow-up of HIV-infected children, HIV and nutrition services
must reach beyond clinics into communities. Social norms, stigma, gender-based inequities
and socioeconomic conditions profoundly influence the ability of women to put messages
from healthcare providers into practice. Consistently, poor infant feeding practices in the
general population and high rates of nonadherence to drug regimens are evidence of a poor
enabling environment and the challenge associated with changing behaviours. In low-
resource/high-HIV-burden countries that recommend breastfeeding of HIV-exposed infants,
communities must be mobilized to support exclusive breastfeeding and optimal
complementary feeding for all infants. Women need support to answer their questions about
IYCF, adhere to ART, maintain their own health and provide optimal care to their children.
Common questions and knowledge gaps around optimal infant feeding for women with HIV
are listed below:
1. Is it safe for a woman with HIV to breastfeed?
2. Why is it safe to feed infants a mix of breast milk and other foods after 6 months
but not before 6 months?
3. How long should women with HIV breastfeed?
4. Do ARVs cause problems during breastfeeding?
5. Does breastfeeding cause health problems such as too much weight loss for women
on ART?
6. What does ‘gradual weaning’ mean?
7. When syrup medicines are not available for infants younger than 6 months, should
medicine be mixed with breast milk or water?
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There is programmatic evidence that it is possible to improve EBF rates among mothers
with HIV. Exclusive breastfeeding rates increased with intentional acceleration and multi-
pronged system strengthening efforts that focused on health facility and community level
point of care support (Fig. 2). Such improvement could positively influence infant feeding
practices in the general population.
Effective mechanisms for tracking mother/infant pairs after they leave the clinic are
essential to increase service uptake and retention, improve adherence to ART and IYCF
recommendations and monitor infant nutritional and HIV status. Community counselling
and follow-up are particularly critical during times of transition in order to avoid confusion
about introduction of complementary foods or weaning. Determining whether an adequate
diet can be provided without breast milk requires individual support and linkage to food
security interventions, particularly when family foods cannot meet the nutritional needs of
growing children with additional energy needs caused by HIV.
At health facility level
Healthcare providers need training, job aids and guidance to provide consistent, accurate and
culturally acceptable IYCF counselling and services to support pregnant women and new
mothers with HIV. Irregular and poor-quality training and supervision can result in mixed or
incorrect feeding messages. Healthcare providers also need guidance to counsel and support
clients whose situation may need individualized care. Training and implementation plans
should address referral linkages between facility services and community care to avoid gaps
in support and follow-up.
Growth faltering of HIV-infected infants begins early [37], but few countries have been
successful in scaling up early infant testing or keeping infants in appropriate care and
treatment for the duration of exposure. Weak health systems, inadequately trained staff and
ineffective follow-up mechanisms make it difficult to track infants at risk. Early HIV testing
and initiation of ARVs can help infants and young children recover lost weight and height to
improve their chances of survival. Countries should urgently scale up efforts to undertake
active case- finding of children whose mothers may have been be missed during the
antenatal period or were infected during the postnatal period, improve testing and follow-up
of all HIV-exposed infants through the weaning period, and ensure that HIV-infected
children remain in treatment. Nutrition assessment should be part of all paediatric care and
treatment, guided by country contexts and local epidemiology of both malnutrition and HIV.
Healthcare providers and volunteers should trained to refer children identified with failure to
thrive and severe growth faltering promptly for HIV testing in high-prevalence areas.
At national level
Countries need costed and sufficiently detailed implementation plans to operationalize IYCF
guidelines for women with HIV. Plans should be guided by technical experts, stakeholder
consensus at all service delivery levels, and collaboration among ministries of health,
education and finance to build political will and enable appropriate resource allocation. In
2012, UNICEF assessed implementation of the 2010 WHO HIV and infant feeding
guidelines in 25 countries in Africa. The assessment found that 24 of the 25 countries had a
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national policy on HIV and infant feeding but only 12 had a related implementation plan and
only six of those 12 plans were costed [38]. Planning must consider in which settings to
reach mothers, how to make services appealing and accessible and how much it will cost to
deliver them.
An integrated, real-time monitoring and evaluation (M&E) system for collecting, analyzing
and using breastfeeding, replacement feeding and mixed feeding data is a critical component
of a national IYCF implementation plan. Such a system is lacking in many countries with
high HIV burden. Countries do not routinely report infant feeding practices in their annual
reports. Current estimates come from general population surveys such as multiple indicator
cluster surveys (MICS) and demographic and health surveys (DHS), which are done every 3
or 5 years and often do not provide sufficient information to identify service gaps or
improve programming. National M&E systems also do not adequately document qualitative
information such as provision of breastfeeding counselling. IYCF programmes should make
more use of qualitative or mixed method studies to obtain reliable data to inform policy and
advice programme improvements.
Preliminary data from a WHO-funded pilot study showed that routine data collection on
infant feeding practices using 24-hour recall is feasible and reliable [39]. Indicators included
the percentage of HIV-exposed infants who received exclusive breastfeeding, exclusive
replacement feeding or mixed feeding at 3 months of age and ARV uptake among HIV-
exposed breastfed infants. Results showed that infant feeding practices for HIV-exposed
infants during the first 6 months can be reported as a national indicator.
Data collection and reporting become more challenging during the complementary feeding
period, and effective recording systems are lacking. Proposed IYCF indicators should be
integrated into strengthened maternal and child health M&E systems, with the aim of
consolidating them into one harmonized system instead of working in parallel.
At global level
Neither the Global AIDS Response Progress Reporting (GARPR) nor President’s
Emergency Plan for AIDS Relief (PEPFAR) require implementing partners to share data on
infant nutritional status or feeding practices. The UNAIDS Indicator Registry includes four
indicators related to IYCF. (The current UNAIDS Indicator Registry includes two WHO
indicators on infant feeding: distribution of feeding practices (exclusive breastfeeding,
replacement feeding, mixed feeding/other) for infants born to women with HIV and women
receiving counseling on infant feeding at the first infant follow-up visit. UNICEF indicators
in the registry include distribution of feeding practices as well as the comparative nutritional
status of orphans and vulnerable children (OVC) and non-OVC at 4 years of age.) A joint
consultative group including WHO, UNAIDS, UNI-CEF, the Global Fund to Prevent AIDS,
Tuberculosis and Malaria; the World Bank, WFP, PEPFAR and others, has proposed
globally harmonized indicators on HIV-free survival at 12 months of age; maternal and
infant nutritional status; and infant feeding status at 3, 6, and 9 months of age. Countries
must be encouraged and supported to report annually on these indicators.
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IYCF service delivery challenges will become more acute with efforts to roll out lifelong
ART to all pregnant women with HIV, regardless of CD4 cell count. As countries review
and amend their national PMTCT guidelines, the time is ripe to address implementation
challenges by ensuring that IYCF plans, M&E and training are developed in tandem.
Evidence gaps
Existing evidence-based nutrition interventions can improve the nutrition and well being of
HIV-infected children, but there has been little research on the impact of specific nutrition
interventions on HIV-infected children on ARVs. In 2009, WHO released Guidelines for an
Integrated Approach to Nutrition Care of HIV-Infected Children (6 Months–14 Years) to
help assess and classify nutritional status and develop nutrition care plans. This was an
important step in mainstreaming nutrition into HIV care. WHO needs to update guidance on
nutritional support for people with HIV in light of the expanded availability of ARVs and
document more evidence on how to reach HIV-infected children successfully in low-
resource settings with these proven interventions. Many women drop out of PMTCT
programmes during the postnatal period resulting in missed opportunities to test infants for
HIV; provide nutrition assessment, counselling and support; and initiate ART before severe
growth failure or immune suppression reduces the efficacy of interventions and the odds of
survival.
More evidence is needed to inform not only implementation but also HIV prevention,
starting in pregnancy, and treatment of malnutrition in HIV-exposed and HIV-infected
children. There is little evidence on whether or how nutrition-related care for HIV-infected
children should differ from that for HIV-negative children. More scientific evidence is
needed to understand the cause of HIV-associated growth faltering and to develop cost-
effective interventions to promote adequate height and weight. Programme-based studies on
supplementary feeding and nutritional rehabilitation of HIV-positive children are needed to
identify practical options to improve linear growth and body composition, and slow disease
progression in resource-constrained settings. Evidence is also lacking on the safety and
effect on infant growth and development of longer-term exposure to ARVs. Continued
pharmacovigilance is necessary to inform the on-going risk-benefit analysis.
Implementation questions will continue to arise as protocols change and trends in lifelong
treatment uptake emerge. Women’s ART adherence needs to be tracked throughout the
breastfeeding period and beyond. The effects of early infant testing on continuation of
breastfeeding also need to be carefully monitored.
Conclusion
It is critical to promote optimal growth, health and development for all infants from birth to
2 years of age. Sub-optimal IYCF and caring practices and high rates of infections have a
detrimental impact on health and growth during these important years. For the best possible
infant health and development outcomes, all mothers, including those living with HIV must
adopt optimal infant feeding practices that maximize protection against early childhood
illnesses and lower the risk of HIV infection. Nutrition assessment, counselling and support
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should be a central part of the care and treatment of HIV-infected children to improve their
health and survival outcomes.
Despite the availability of evidence-based recommendations and guidelines, misconceptions
and confusion about safer IYCF practices persist in developing countries. Lack of national
data coupled with implementation challenges limits the ability of programmes to make
appropriate improvements. Governments and implementers should focus on practical and
effective approaches to training and supervising healthcare providers; increasing PMTCT
and nutrition service uptake; and strengthening health systems, including mechanisms to
track mother/infant pairs and national monitoring and reporting of globally agreed infant
feeding indicators.
The success of ARVs in lowering HIV transmission and improving maternal treatment is
limited by knowledge gaps about optimal maternal regimens, duration of infant prophylaxis,
and the short-term and long-term effects on children of prolonged ARV exposure through
breast milk. To inform global recommendations, new ART regimens and possibly vaccines,
which enable women with HIV to breastfeed without consideration of duration should be
identified, and health system interventions that improve adherence to postnatal ARVs and
breastfeeding should be tested.
Despite significant progress toward keeping mothers alive and reducing paediatric HIV,
challenges remain for operationalizing evidence-based recommendations. Sustained
political, financial and scientific commitments are key to eliminate mother-to-child HIV
transmission while protecting the health and well being of all mothers and children.
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Fig. 1. Energy required by age and provided by breast milk
Source: WHO. Infant and Young Child Feeding: Model Chapter for Textbooks for Medical
Students and Allied Health Professionals. Geneva: WHO; 2009.
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Fig. 2. Rates of exclusive breastfeeding (EBF) in the general population and for HIV-positive
mothers in Kenya, 2003–2012
Source: Kenya Demographic and Health Survey (KDHS) 2003 and 2008; Kenya Ministry of
Health (MOH) district surveys, 2012; Kenya National PMTCT evaluation, 2010; and
Nyanza Programme data.
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Table 1
Composition of breastmilk.
Component Fats: 3.5 g per 100 ml [docosahexaenoic acid (DHA) and
arachidonic acid (ARA)]
Benefit Neurological development
Carbohydrates: 7 g per 100 ml (lactose and oligosaccharides) Energy and protection against infection
Protein: 0.9 g per 100 ml (casein, α-lactalbumin) Growth and development
Vitamins: All except K Optimal growth and development
Minerals: Sodium, potassium, calcium, magnesium, phosphorus, chlorine Optimal growth and development
Anti-infective factors: IgA, white blood cells Immunity and protection against inflammation, bacteria and
other pathogens
Other bioactive factors: bile-salt stimulated lipase, epidermal growth factor Digestion, maturity of the infant’s intestinal lining
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